In Vitro Diagnostics Market Research Reports & Industry Analysis
In Vitro Diagnostics Industry Research & Market Reports
-
Digital Pathology Systems
... at a CAGR of 12.8% over the analysis period 2024-2030. Device, one of the segments analyzed in the report, is expected to record a 12.7% CAGR and reach US$1.1 Billion by the end of the ... Read More
-
Prenatal Diagnostics
... CAGR of 12.8% over the analysis period 2024-2030. Non-Invasive, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$10.6 Billion by the end of the analysis period. ... Read More
-
Lateral Flow Assays
... at a CAGR of 5.3% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$12.3 Billion by the end ... Read More
-
Clinical Microbiology Instruments and Reagents
... Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$2.4 Billion by ... Read More
-
Electrophoresis Equipment and Supplies
... 2030, growing at a CAGR of 3.0% over the analysis period 2024-2030. Gel Electrophoresis Systems, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$1.2 Billion by ... Read More
-
Forensic Technologies and Services
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the end ... Read More
-
ADME-Toxicology Testing
... CAGR of 11.2% over the analysis period 2024-2030. Cell Culture, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$9.6 Billion by the end of the analysis ... Read More
-
Metabolic Testing Solutions
... at a CAGR of 6.8% over the analysis period 2024-2030. CPET Systems, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$324.1 Million by the end of ... Read More
-
Commercial Biotechnology Separation Systems
... 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Conventional, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$19.0 Billion by the end ... Read More
-
Cytology Brushes
... CAGR of 6.1% over the analysis period 2024-2030. Metal, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$71.9 Billion by the end of the analysis period. ... Read More
-
Bioanalytical Testing Services
... at a CAGR of 7.0% over the analysis period 2024-2030. Small, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$4.7 Billion by the end of the ... Read More
-
Veterinary Rapid Testing
... at a CAGR of 8.3% over the analysis period 2024-2030. Kits, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$1.1 Billion by the end of the ... Read More
-
Rabies Diagnostics
... CAGR of 5.4% over the analysis period 2024-2030. Fluorescent Antibody Tests (FAT), one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$910.1 Million by the end of ... Read More
-
Point of Care Data Management Software
... reach US$2.0 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach ... Read More
-
Blood Culture Tests
... at a CAGR of 5.9% over the analysis period 2024-2030. Conventional Blood Culture Tests, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.3 Billion by the ... Read More
-
Genetic Testing
... CAGR of 9.9% over the analysis period 2024-2030. Cancer, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$13.6 Billion by the end of the analysis period. ... Read More
-
Flow Cytometry Products and Services
... Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Cell-Based Flow Cytometry, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.8 ... Read More
-
Titrators (Automatic and Manual)
... 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Coulometric, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$334.3 Million by the end ... Read More
-
Clinical Diagnostics Automation
... at a CAGR of 6.5% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.5 Billion While China is Forecast to Grow at 10.6% CAGR The Clinical Diagnostics Automation market in the U.S. ... Read More
-
Tissue Diagnostics
... CAGR of 6.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$8.4 Billion by the end of the analysis period. ... Read More
-
Veterinary Hematology Analyzers
... at a CAGR of 5.3% over the analysis period 2024-2030. Table Top Analyzers, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end ... Read More
-
Cancer / Tumor Profiling
... 2030, growing at a CAGR of 9.9% over the analysis period 2024-2030. Immunoassays, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$6.7 Billion by the end ... Read More
-
Coagulation Factor Concentrates
... at a CAGR of 7.2% over the analysis period 2024-2030. Hospitals & Clinics, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$8.8 Billion by the end ... Read More
-
Blood Screening
... CAGR of 5.5% over the analysis period 2024-2030. Blood Screening Reagents & Kits, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.7 Billion by the end ... Read More
-
Cell Isolation / Cell Separation
... Billion by 2030, growing at a CAGR of 16.8% over the analysis period 2024-2030. Cell Isolation / Cell Separation Consumables, one of the segments analyzed in the report, is expected to record a 19.5% CAGR ... Read More
Research Assistance
